Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249–54.
Thomas AS, Mehta A, Hughes DA. Gaucher disease: haematological presentations and complications. Br J Haematol. 2014;165:427–40.
Thomas AS, Mehta AB, Hughes DA. Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists. Blood Cells Mol Dis. 2013;50:212–7.
Joo EY, Kim KY, Kim DH, Lee JE, Kim SK. Iron deficiency anemia in infants and toddlers. Blood Res. 2016;51:268–73.
Wang M. Iron deficiency and other types of anemia in infants and children. Am Fam Physician. 2016;93:270–8.
Lim JY. Iron deficiency anemia in infants and young children. Clin Pediatr Hematol Oncol. 2014;21:47–51.
Beutler E. Enzyme replacement in Gaucher disease. PLoS Med. 2004;1:e21.
Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of nonneuronopathic gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med. 2006;160:603–8.
Zimran A, Altarescu G, Rudensky B, Abrahamov A, Elstein D. Survey of hematological aspects of Gaucher disease. Hematology. 2005;10:151–6.
Orkin SH. Nathan and Oski’s hematology and oncology of infancy and childhood. Philadelphia: Elsevier Saunders; 2015.
Tibblin E, Dreborg S, Erikson A, Håkansson G, Svennerholm L. Hematological findings in the Norrbottnian type of Gaucher disease. Eur J Pediatr. 1982;139:187–91.
El-Beshlawy A, Tylki-Szymanska A, Vellodi A, Belmatoug N, Grabowski GA, Kolodny EH, et al. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Mol Genet Metab. 2017;120:47–56.
Benoist DB, McLean E, Egll I, Cogswell M. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia: Geneva: World Health Organization. 2008.
DeLoughery TG. Microcytic anemia. N Engl J Med. 2014;371:1324–31.
Di Rocco M, Andria G, Deodato F, Giona F, Micalizzi C, Pession A. Early diagnosis of Gaucher disease in pediatric patients: proposal for a diagnostic algorithm. Pediatr Blood Cancer. 2014;61:1905–9.
Ida H, Rennert OM, Iwasawa K, Kobayashi M, Eto Y. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation. Hum Genet. 1999;105:120–26.
Jeong SY, Park SJ, Kim HJ. Clinical and genetic characteristics of Korean patients with Gaucher disease. Blood Cells Mol Dis. 2011;46:11–4.
Lee JY, Lee BH, Kim GH, Jung CW, Lee J, Choi JH, et al. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups. Korean J Pediatr. 2012;55:48–53.
Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82:697–701.
Ito S, Barrett AJ. Gauchers disease–a reappraisal of hematopoietic stem cell transplantation. Pediatr Hematol Oncol. 2013;30:61–70.